Mobile

An Exploratory, Multi-center, Open-Label, Single-Arm study to evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent (DECADES) on Inflammatory and Platelet Activation Markers in S...

Mise à jour : Il y a 5 ans
Référence : EUCTR2007-000713-11

An Exploratory, Multi-center, Open-Label, Single-Arm study to evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent (DECADES) on Inflammatory and Platelet Activation Markers in Subjects Who Are Receiving Low Dose Acetylsalicylic Acid (ASA)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess if the withdrawal of clopidogrel 12 months after DES implantation leads to an increase in the level of soluble CD40 Ligand over a four weeks follow-up period.

Critère d'inclusion

  • Biomarkers of inflammation and platelet activation

Liens